A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease
Year: 2006
Type: article
Study design: Clinical Trial
Source: Inflammatory Bowel Diseases
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keyword: IL-12/23 inhibitors
Open Access status: closed
OpenAlex ID: W2167451347
